CA
MAZE

Cliff Asness’s Maze Therapeutics MAZE Stock Holding History

Cliff Asness’s Portfolio MAZE Stock Details MAZE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$810K Sell
27,161
-784
-3% -$20.5K ﹤0.01% 3124
2026
Q1 		$834K Buy
27,945
+506
+2% +$22.3K ﹤0.01% 2870
2025
Q4 		$1.14M Sell
27,439
-176
-0.6% -$6.05K ﹤0.01% 2476
2025
Q3 		$716K Buy
27,615
+148
+0.5% +$2.5K ﹤0.01% 2622
2025
Q2 		$337K Buy
+27,467
New +$286K ﹤0.01% 2804

Other funds holding MAZE

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return

Cliff Asness's MAZE Position: Q2 2026 in Review

Cliff Asness reduced its Maze Therapeutics (MAZE) stake by 2.8% in Q2 2026, selling an estimated $20.5K and leaving 27,161 shares worth $810K. The position accounts for ﹤0.01% of the portfolio, ranked #3124.

Cliff Asness first reported a position in MAZE in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.14M in Q4 2025. 161 funds tracked by Wall St. Rank hold MAZE as of Q2 2026.

  • Cliff Asness held 27,161 shares of Maze Therapeutics worth $810K as of Q2 2026.
  • Cliff Asness sold 784 Maze Therapeutics shares in Q2 2026, an estimated $20.5K.
  • Maze Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3124 holding.
  • Cliff Asness first reported a position in Maze Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • Cliff Asness's Maze Therapeutics position peaked at $1.14M in Q4 2025.
  • 161 funds tracked by Wall St. Rank held Maze Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.